Healthcare Perspectives is a podcast by Siemens Healthineers about medical breakthroughs with the power to improve the lives of patients and their families everywhere.
Meet thought leaders from across the globe, as we discuss our shared vision of fighting the world's most threatening diseases through breakthrough medical technology. Hear how technologies like patient twinning, precision therapy and digitization help medical professionals to make the best possible decisions.
6f0570b4ce66aaf30246c7f725e75cf511acc6f2
Hosted on Acast. See acast.com/privacy for more information.
Healthcare Perspectives is a podcast by Siemens Healthineers about medical breakthroughs with the power to improve the lives of patients and their families everywhere.
Meet thought leaders from across the globe, as we discuss our shared vision of fighting the world's most threatening diseases through breakthrough medical technology. Hear how technologies like patient twinning, precision therapy and digitization help medical professionals to make the best possible decisions.
6f0570b4ce66aaf30246c7f725e75cf511acc6f2
Hosted on Acast. See acast.com/privacy for more information.
Lung cancer has the highest mortality rate of all cancers. Globally, it is the deadliest cancer among men and women. One of the biggest contributing factors to lung cancer’s devastation is that it often goes undetected in its early stages. Because the lungs don’t have pain receptors and the chest cavity allows a relatively spacious growing environment for tumors, symptoms typically don’t manifest until the disease has progressed significantly. It’s for these reasons that screening higher-risk patients for lung cancer is so important, as early detection provides the best chance of survival from the disease.
In this episode, Dr. Victoria Schneider, clinical oncology consultant at Siemens Healthineers, is joined by Dr. Richard Booton, clinical director for lung cancer and thoracic surgery at Wythenshawe Hospital and professor of respiratory medicine at the University of Manchester in the UK; Rimma Kondrashova, a radiology resident at Hannover Medical School in Germany; and doctors David Yankelevitz and Claudia Henschke, both radiologists and professors of radiology at Mount Sinai’s Icahn School of Medicine in New York City.
You’ll hear from these experts about the importance of early detection, the programs that have been recently rolled out to increase survival rates, and some of the exciting new advancements in the field.
What You’ll Learn in This Episode:
• Early detection is a key factor in the successful treatment of lung cancer
• Government funded screening programs in the US and the UK have made significant headway in early-stage lung cancer diagnoses
• In Germany, the HANSE Study was created to assess what a successful national lung cancer screening program might look like for the country
• Mobile screening clinics have been implemented in order to move lung cancer screenings out of hospitals and into more readily accessible community spaces
Connect with Victoria Schneider
Connect with Richard Booton
Connect with David Yankelevitz
Connect with Claudia Henschke
Hosted on Acast. See acast.com/privacy for more information.